When to use an at-home colorectal cancer screening test instead of a colonoscopy

A colorectal cancer specialist discusses non-invasive stool tests and if you should use them

5:00 AM

Author | Jina Sawani

person with stomach pain purple and grey coloring and at home stool test
Justine Ross, Michigan Medicine

Colorectal cancer, or collectively, cancers that develop in the colon and/or rectum, are currently on the rise. The United States Preventive Services Task Force recommends that adults begin screening for colorectal cancer at the age of 45.

But when should someone use an at-home colorectal cancer screening test versus scheduling a traditional colonoscopy?

Elena Stoffel, M.D., M.P.H., director of cancer genetics at the University of Michigan Rogel Cancer Center, recently spoke to Health Lab about at-home stool tests and when to use them. 

How would you describe these at-home screening tests?

Stoffel: I think it’s important to remember that colonoscopies are still the gold standard when it comes to colon cancer screening. Colonoscopies are the only test approved for screening patients that are at a higher-than-average risk for colorectal cancer.

Currently, there are other non-invasive tests available, but they are only approved for individuals who are at average risk for colorectal cancer. These tests can be ordered by the patient or their provider(s) and involve securely sending a stool sample to a testing facility. 

SEE ALSO: Improving the Colonoscopy Process: How to Have a More Comfortable Colonoscopy (michiganmedicine.org)

If someone then tests positive on a stool-based colorectal cancer screening test, it is recommended that they undergo a colonoscopy. 

These non-invasive tests have evolved over time. How accurate are they?

Stoffel: The non-invasive tests that are looking for blood in the stool are referred to as fecal immunochemical tests, or FIT tests. Essentially, they use antibodies to detect blood in the stool.

There are other non-invasive stool tests, like Cologuard, which detect blood in the stool, as well as DNA markers that have been found in colorectal cancer tumors. The old stool-based colorectal cancer screening tests that were used in the early 1990s were not nearly as good as today’s FIT tests. The sensitivities surrounding these newer tests give them about an 80% accuracy rate for detecting colorectal cancers.

The FIT test is good for detecting colorectal cancer, but not for identifying polyps. This is very important to remember, especially if you’re hoping to prevent colorectal cancers by detecting and removing pre-cancerous polyps. In this case, you’ll need a colonoscopy.

Who are these non-invasive tests for, in particular?

Stoffel: The non-invasive colorectal cancer screening tests are really designed for asymptomatic individuals who are at average risk for developing colorectal cancer.

Anyone who has colorectal cancer symptoms, a family history of colorectal cancer (i.e., a first degree relative with colorectal cancer) or has had one or more large pre-cancerous polyps (from things like inflammatory bowel disease, Crohn's disease and other gastroenterological conditions) should have a colonoscopy, rather than a non-invasive screening test.

SEE ALSO: A Doctor’s Mission: Get More People Screened for Colon Cancer

Another thing that is important to note is that non-invasive stool-based colorectal cancer screening tests should be repeated every one to three years, whereas a normal colonoscopy screening test can protect against colon cancer for about 10 years. And if colon polyps are removed before they become cancerous, most cases of colorectal cancer can be prevented.

Therefore, colonoscopies are not merely a colon cancer detection test, they are also a colon cancer prevention test. Many at-home, non-invasive tests are good at detecting cancer, but not preventing it. 

Is there anything important related to these screening modalities people should know?

Stoffel: There’s a lot in the news today about new blood tests for detecting cancers. While the technologies are exciting, they’re far from perfect. There can be false negatives and false positives.

Some of the laboratories involved in developing these tests have algorithms to determine if a positive blood-based cancer test corresponds to a colorectal cancer (versus another type of cancer), but one of the downsides of this process is figuring out what the next steps are.

SEE ALSO: Black patients more likely to get emergency colorectal cancer surgery | Michigan Medicine

If a blood test comes back positive, should a patient get a colonoscopy or a CT scan first? And if the colonoscopy is negative, what additional testing is required to rule out other cancer types? The NIH is conducting studies to examine the risks and benefits of these new blood tests for cancer detection.

Ultimately, our goal is to help get as many people screened for colorectal cancer as possible. So, individuals that are age 45 and older who are of average risk of developing colorectal cancer are encouraged to consider these non-invasive screening tests.

Meanwhile, those who are deemed to be at higher-than-average risk for colorectal cancer or who test positive on a non-invasive test should make their colonoscopy appointments sooner.

More Articles About: Digestive Health Digestive Diseases Polyps Cancer Care Preventative health and wellness Colorectal Cancer Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Featured News & Stories Animated microscopic image of the glioblastoma's tumor microenvironment
Health Lab
New model of key brain tumor feature could help scientists understand how to develop new treatments
Model shows how oncostreams form and behave in brain tumors – and how to inhibit them
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.
cancer cell blue yellow
Health Lab
Targeted drug shows promising ability in treating rare head and neck cancers
Experts at Rogel Cancer Center develop and study the impact of a new drug for salivary gland cancers
Health care provider with stethoscope holds patient's hand
Health Lab
Combatting prostate cancer stigma
Prostate cancer is highly treatable and over 98% of men survive 10 years if the cancer is diagnosed and treated early.
Drawing of parent trying to get child's attention who is listening to music on headphones
Health Lab
Are headphones and earbuds exposing your children to noise health risks?
2 in 3 parents in national poll say their child ages 5-12 use personal audio devices; pediatrician offers 4 tips to reduce noise exposure risks
patient end of bed in hospital looking out window with stuffed animal on bed
Health Lab
Studying cells to improve medulloblastoma treatment
Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.